Altrubio

Developer of drugs for immune-mediated inflammation and cancer therapies

placeSan Francisco, California, United States groups10 employees language altrubio.com

Investor mix

8 investors on record; lead investors include aMoon, BVF Partners.

Investor typeCountShare
Venture capital225%
Private equity338%
Other / undisclosed338%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

11 Sep 2025 · Chief Scientific Officer · San Francisco

Based on job postings tracked across public sources.

Coming soon